Abstract:
—Chronic myeloid leukemia (CML) is a myelo
proliferative disorder characterized by proliferation of the
granulocytic cell line. The incidence of CML in Kenya is
estimated at near 2000 cases annually. The disorder is
associated with a poor prognosis without treatment.
Tyrosine kinase inhibitors are approved for treatment in
adults and children with confirmed disease. Diagnostic
testing for CML in the public setting in Kenya is limited
and not covered by the Kenyan National Health Insurance
Fund.
